Investments (#)
Investments (USD)
Transactions
Recent transactions in the domain of pharmaceuticals
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
Neurelis Inc Neuroscience company. |
United States | Series D USD 114,000,000 (USD 114,000,000) |
10 Mar 2021 |
|
Digi-Prex Online subscription pharmacy that deliver patients with chronic diseases their prescriptions. |
India | Seed USD 5,500,000 (USD 5,500,000) |
20 Sep 2019 |
|
Stemcentrx Inc Cancer drug development company. |
United States | Acquisition USD 10,200,000,000 (USD 10,200,000,000) at USD 10,200,000,000 (USD 10,200,000,000) valuation. |
28 Apr 2016 |
|
|
Stemcentrx Inc Cancer drug development company. |
United States | Series G USD 250,000,000 (USD 250,000,000) |
1 Sep 2014 |
|
|
Stemcentrx Inc Cancer drug development company. |
United States | Series F USD 200,000,000 (USD 200,000,000) |
1 May 2014 |
|
Lumena Pharmaceuticals Inc |
United States | Series A USD 23,000,000 (USD 23,000,000) |
8 May 2013 |
|
Intrexon Corp |
United States | Series E USD 100,000,000 (USD 100,000,000) |
1 Jun 2011 |
|
|
Stemcentrx Inc Cancer drug development company. |
United States | Series C USD 23,530,000 (USD 23,530,000) |
1 Mar 2011 |
|
Acadia Pharmaceuticals Inc Small molecule drug discovery and development company. |
United States | Venture |
1 Jan 2011 |
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | Venture |
1 Aug 2010 |
|
|
Acelrx Pharmaceuticals Inc Specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain. |
United States | Debt |
31 Dec 2008 |
|
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | N/A |
1 Aug 2008 |
|
Zysis Ltd A privately-owned pharmaceutical company optimizing therapies for disorders of the Central Nervous System to improve sufferers’ lives. |
United Kingdom | N/A |
31 Dec 2007 |
|
|
Intrexon Corp |
United States | Series C USD 25,000,000 (USD 25,000,000) |
15 May 2007 |
|
GlycoFi Inc |
Series C |
1 Dec 2003 | |
|
|
GlycoFi Inc |
N/A |
1 Apr 2002 | |
|
|
GlycoFi Inc |
N/A |
1 Nov 2000 |
Companies
Best funded companies in pharmaceuticals
Cancer drug development company.
Investment themes:
Online subscription pharmacy that deliver patients with chronic diseases their prescriptions.
Investment themes:
AI-driven pioneer in drug formulation.
Investment themes:
US specialty pharmaceutical company
Investment themes:
Small molecule drug discovery and development company.
Investment themes:
Pharmaceutical Labeling Software, Regulatory Labeling Management
Investment themes:
A privately-owned pharmaceutical company optimizing therapies for disorders of the Central Nervous System to improve sufferers’ lives.
Investment themes:
Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.
Investment themes:
Specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain.
Investment themes:
Investors
Top investors in the domain of pharmaceuticals
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
Acquirers
Top acquirers in the domain of pharmaceuticals
| Investor | Profile | Country | Acquisitions | |
|---|---|---|---|---|
|
|
Viatris | 1 | ||
|
Abbvie Inc | United States | 1 |